Australia's largest stock trading and investment forum Australia's #1 stock forum

IBX

Click for more information

0.00%

8.2¢ imagion biosystems limited

the question in your post warrants its own discussion topic.a...

First 77 Last

Share
Profile

Follow
Looking4ideas

229 Posts.

108

30/07/21

15:22

Post #: 54910019
Share

Originally posted by ainsleym: ↑

I ask one simple question of management ( perhaps Geoff Hollis as CFO based here would care to comment and put us all in the picture as we know he does read HotCopper and does post on HC as needs be. My question is, how do you reconcile the "on track" comment by the CEO in the July 2 video presentation at the 4 minute mark with the announcement of today which clearly demonstrates we are NOT ( and were not) on track for completion by year end. Clearly those sharing their comments in this thread have the same issue with trying to reconcile the two seemingly different sets of advice in such a short period of time ( July 2 until today). The excuse that having more sites will put us on track provides me and likely most others with no comfort. There is a case to be answered here and we would appreciate an explanation regarding the two statements ( July 2 and todays announcement) which are at odds with each other. I might add that no doubt some shareholders would have taken the comment by the CEO on July 2 in good faith and that could well have influenced their investment decision. Over to you Geoff..... investors want an answer.

Expand

the question in your post warrants its own discussion topic.

a fair question the demands a fair response.

IBX Price at posting: 7.1¢ Sentiment: Hold Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

There are more pages in this discussion • 46 more messages in this thread...

First 77 Last

Add IBX (ASX) to my watchlist

(20min delay)
Last 8.2¢		Change 0.000(0.00%)		Mkt cap ! $2.677M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	10941	8.2¢

Sellers (Offers)

Price($)	Vol.	No.
8.5¢	305	1

View Market Depth

No.	Vol.	Price($)
2	10941	0.082
1	15000	0.081
3	62156	0.080
1	13155	0.076
2	32500	0.075

Price($)	Vol.	No.
0.085	305	1
0.086	16254	1
0.087	1250	1
0.088	8563	1
0.089	295	1

Last trade - 16.12pm 09/07/2024 (20 minute delay)

IBX (ASX) Chart

Day chart unavailable